Table of Contents
|FDA Approves Novel Preventive Treatment for Migraine||Abstract PDF|
|FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy||Abstract PDF|
|FDA Approves First-of-its Kind Targeted RNA-based Therapy to Treat a Rare Disease||Abstract PDF|
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.